Patents
Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
10/2001
10/17/2001EP0640065B1 Trisubstituted phenyl derivatives as phosphodiesterase inhibitors and processes for their preparation
10/17/2001CN1318054A Novel compounds
10/17/2001CN1317970A Method for treating atherosclerosis empolying ap2 inhibitor and combination
10/16/2001CA2025301C New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase
10/11/2001WO2001074788A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use
10/11/2001CA2405132A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use
10/10/2001EP1141140A1 Naphthalenehydrazamimides and perylenehydrazamimides
10/10/2001EP1140768A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
10/09/2001US6300330 Blood coagulation factor x inhibitors as anticoagulants
10/04/2001WO2001072305A1 A medicament and method for the production thereof
10/04/2001EP1137641A1 Process for preparing pyridazin-3-on derivatives
10/03/2001CN1315945A Nitrate salts of antihypertensive medicines
09/2001
09/27/2001WO2001070706A2 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
09/27/2001WO2001017972A3 Novel herbicides
09/27/2001US20010025051 Administering to a breast cancer patient an effective amount of hydroxy containing bicyclic aromatic or heteroaromatic derivatives
09/27/2001US20010025032 Administering mixture of nucleosides; anticancer agent
09/27/2001CA2400000A1 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
09/25/2001US6294580 For therapy and prophylaxis of type ii or non-insulin dependent diabetes mellitus, hyperglycaemia, dyslipidemia, type ii diabetes, type i diabetes, hypertriglyceridemia, syndrome x, insulin resistance, heart failure
09/20/2001WO2001068619A1 5-amide substituted diarylamines as mex inhibitors
09/20/2001WO2001068611A1 Pyridazinyl phenyl hydrazones useful against congestive heart failure
09/20/2001WO2001068585A1 Novel amide compounds
09/20/2001CA2403188A1 Pyridazinyl phenyl hydrazones useful against congestive heart failure
09/20/2001CA2403017A1 5-amide substituted diarylamines as mex inhibitors
09/19/2001EP1133486A2 Nonsteroidal antiinflammatories
09/19/2001EP0923529B1 Substitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
09/19/2001CN1313846A C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cystenine proteases
09/19/2001CN1313768A Nitrogenous heterocyclic carboxamide derivatives or salts thereof and antivirual agents containing both
09/18/2001US6291425 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
09/18/2001US6291400 Herbicidal compounds
09/13/2001WO2000032573A8 A meta-nitro phenol derivative and a process for producing it
09/12/2001EP0888317B1 Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma
09/12/2001EP0794945B1 Iminooxybenzylcrotonic acid esters, process for their preparation and use thereof
09/12/2001EP0749424B1 Naphthalene derivatives as prostaglandin i2 agonists
09/12/2001EP0693482B1 Process for producing hexahydropyridazine and hexahydropyridazine-1,2-dicarboxylate derivative
09/11/2001US6288064 Phosphodiesterase inhibitors; phthalazine derivatives
09/07/2001WO2001064652A1 Substituted 5-methyldihydropyridazinones and their use in the prophylaxis and/or treatment of anemias
09/07/2001WO2001064635A1 Ningalin b analogs employable for reversing multidrug resistance
09/07/2001CA2401673A1 Ningalin b analogs employable for reversing multidrug resistance
09/06/2001DE10010430A1 Medicaments, especially for treating anemia, containing 6-(4-(acylamino)-phenyl)-5-ethyl-dihydropyridazinones having erythropoietin sensitizing and erythropoiesis stimulating activity
09/06/2001DE10010429A1 New 6-(4-sulfonamido-phenyl)-5-methyl-dihydropyridazinones, having erythropoietin sensitizing and erythropoiesis stimulating activity, useful for treating anemia
09/06/2001DE10010426A1 Medicaments, especially for treating anemia, containing 6-(4-(acylamino)-phenyl)-dihydropyridazinones having erythropoietin sensitizing and erythropoiesis stimulating activity
09/06/2001DE10010425A1 Medicaments for treating anemia, containing new or known 6-(4-(acylamino)-phenyl)-5-methyl-dihydropyridazinones having erythropoietin sensitizing and erythropoiesis stimulating activity
09/06/2001DE10010422A1 New 6-(4-carboxy-phenyl)-dihydropyridazinone esters or amides, having erythropoietin sensitizing and erythropoiesis stimulating activity, useful for treating anemia
09/05/2001EP1130015A1 Pyridazinone derivatives
09/05/2001EP0699185B1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS
09/04/2001US6284768 Src family SH2 domain inhibitors
08/2001
08/29/2001EP0752998B1 Thionation process using elemental phosphorus and sulfur
08/29/2001CN1310714A Substituted benzoylcyclohexandiones
08/29/2001CN1309898A Pesticide containing 0-benzyl oximeether derivative and its use
08/23/2001WO2000059484A3 Use of arylalkanoylpyridazines
08/23/2001EP1143944A3 Use of arylalkanoylpyridazines
08/22/2001EP1124809A1 Benzoylpyridazines
08/22/2001EP1124804A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
08/16/2001WO2001058901A1 Pyrrolopyridazine compound
08/16/2001WO2001058853A1 Dehydroamino acids
08/16/2001EP1123280A1 Serine protease inhibitor
08/16/2001EP1123272A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
08/16/2001CA2399380A1 Pyrrolopyridazine compound
08/16/2001CA2397993A1 Dehydroamino acids
08/15/2001CN1308068A Pyridazine derivative and its preparation and composite containing the derivative
08/09/2001WO2001056997A1 Process for preparing piperazic acid derivatives thereof
08/09/2001US20010012841 Reacting at least 10 wt % of 4,5-dichloro-3-hydroxypyridazine or 4,5-dibromo-3-hydroxypyridazine or a mixture with atleast 20 vol% of morpholine in a reaction solution at 70 degree C. or higher; Ultraviolet absorbents and photostabilizers
08/08/2001EP1121342A1 Diaminopropionic acid derivatives
08/08/2001EP1121129A1 METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND COMBINATION
08/08/2001CN1307564A Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them
08/07/2001US6271373 Compounds, compositions and methods for treating influenza
08/01/2001CN1306527A Reference compound for use in analysis of levosimendan batches
07/2001
07/31/2001US6268365 Src family SH2 domain inhibitors
07/26/2001WO2001053274A1 Amide compounds for inhibiting protein kinases
07/26/2001WO2001004097A3 Cyclic delocalized cations connected by spacer groups
07/26/2001CA2394703A1 Amide compounds for inhibiting protein kinases
07/25/2001EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
07/25/2001CN1305467A Phthalazine derivatives phosphodiesterase 4 inhibitors
07/25/2001CN1305466A Substituted phenyl pyridazinones
07/25/2001CN1305465A Aryl alkanoylpyridazines
07/25/2001CN1068875C Process for preparation of epsilon-caprolactam and epsilon-caprolactam
07/17/2001US6262295 Process for the preparation of a racemic or optically active 4-(hydroxymethyl)-2-cyclopentene derivative
07/17/2001US6262045 Treatment of anxiety; sleep disorder; epilepsy; spasticity; muscle contracture or an extrapyramidal syndrom; inducing or maintaining anaesthesia
07/11/2001EP1114029A1 Novel compounds
07/11/2001EP1113801A1 METHOD FOR TREATING ATHEROSCLEROSIS EMPLOYING AN aP2 INHIBITOR AND COMBINATION
07/11/2001CN1303281A Use of compounds for elevation of pyruvate dehydrogenase activity
07/10/2001US6258806 Peptides with cyclic diazaalkanes for prevention of premature metabolism method for inhibiting an hiv protease in a mammal in need of such protease inhibition, comprising administering to said mammal an effective dosage
07/04/2001EP1112743A1 Nitrogenous heterocyclic carboxamide derivatives or salts thereof and antiviral agents containing both
07/04/2001EP0925284B1 New polycyclic phthalazin derivatives and their use
07/04/2001CN1067991C Aminoalkyl substituted benzo-heterocyclic compounds
07/03/2001US6255303 Bronchodilator agent
06/2001
06/28/2001WO2001046194A2 Process for the preparation of pyrazolo[1,5-b]pyridazine derivatives
06/28/2001WO2001046127A1 Acyl pseudopeptides bearing a functionalised auxiliary spacer
06/28/2001WO2001046126A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm
06/28/2001WO2001045703A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
06/28/2001CA2395569A1 Process for the preparation of pyrazolo[1,5-b]pyridazine derivatives
06/28/2001CA2395197A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm
06/28/2001CA2393724A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
06/27/2001EP1110945A2 Azocompounds for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
06/27/2001EP1109543A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
06/27/2001EP0733046B1 benzoyl guanidines, their production and their use in medicaments
06/26/2001US6252112 Process for the preparation of an enantiomer of a (1R, 4S) or (1S, 4R)-1-amino-4-(hydroxymethyl)-2-cyclopentene derivative
06/26/2001US6252083 Fungicides, insecticides, nematocides
06/20/2001EP1108712A1 3-Hydroxy-4,5-bis(morpholin-1-yl)pyridazine as UV absorber
06/19/2001USRE37234 Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 85